Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
- Author
- American Thoracic Society
- Published
- Thu 15 Dec 2022
- Episode Link
- https://share.transistor.fm/s/0b43af97
